<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[BIOTEC PHARMACON]]></title><description><![CDATA[<p dir="auto">Helge, er det stadig en god ide at have et frimærke her? Er der noget potentielt der kan sætte en stigning igang<br />
eller bør man tage tabet og komme videre?OKI</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/439492/biotec-pharmacon</link><generator>RSS for Node</generator><lastBuildDate>Sat, 18 Jul 2026 04:10:20 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/439492.rss" rel="self" type="application/rss+xml"/><pubDate>Mon, 18 Jul 2016 07:45:52 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to BIOTEC PHARMACON on Mon, 18 Jul 2016 09:32:23 GMT]]></title><description><![CDATA[<p dir="auto">Jeg beholder mit frimærke.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/9451938</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9451938</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Mon, 18 Jul 2016 09:32:23 GMT</pubDate></item></channel></rss>